Plain-English translation of NCT05207358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a newer treatment approach using (a targeted immune therapy) can work as well as the standard treatment for lupus nephritis while using fewer steroids. Lupus nephritis is a serious complication of lupus where the disease damages the kidneys. The study will compare two different medication regimens over 24 months and check your kidney health with a repeat biopsy at 6 months.
Lupus nephritis requires strong medications to prevent kidney damage, but the standard treatment uses high doses of steroids that can cause serious side effects with long-term use. This trial is exploring whether this newer treatment approach can control the disease effectively while keeping steroid doses much lower.
You likely qualify if…
You likely don't qualify if…
You will have a kidney biopsy at the start to confirm your diagnosis. Then you will be randomly assigned to one of two treatment groups and receive either the standard treatment (high-dose steroids followed by a steroid-sparing regimen with and azathioprine) or the newer approach ( with a different steroid-sparing medication called ). You will take the assigned medications for 24 months and have a second kidney biopsy at 6 months to see how your kidneys are responding. Regular clinic visits will monitor your kidney function and how you're tolerating the treatment.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Romania